patient
Topic(s)
Bone Marrow Transplant
Presenter(s)
Karamjeet Singh Sandhu, MD
Dr. Karamjeet Singh explains the condition of Chronic GVHD, or Graft Versus Host Disease in this recorded session from the 2024 Los Angeles Patient and Family Conference.
Transplant for Aplastic Anemia and MDS - 2024 Los Angeles Patient and Family Conference
Topic(s)
Bone Marrow Transplant
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Presenter(s)
Ryotaro Nakamura, MD
Dr. Ryotaro Nakamura explains the entire process for bone marrow transplantation in this recorded session from the 2024 Los Angeles Patient and Family Conference. Learn the potential ways transplants can help patients with aplastic anemia or MDS.
Advances in Treating Lower Risk MDS - 2024 Los Angeles Patient and Family Conference
Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Brian Ball, MD
Learn about recent research and clinical advances for treating Low-Risk MDS, or Myelodysplastic Syndromes in this session from Dr. Brain Ball.
Emerging Therapies in High-Risk MDS - 2024 Los Angeles Patient and Family Conference
Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Zahra Pakbaz, MD
Discover the most recent treatments and therapies available for High-Risk MDS, or Myelodysplastic Syndromes, in this recorded session featuring Dr. Zahra Pakbaz.
ASH 2023 Update - Aplastic Anemia and PNH
Topic(s)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Aplastic Anemia
Presenter(s)
David Dingli, M.D., Ph.D.
In this webinar, Dr. David Dingli presents the latest research presented the American Society of Hematology meeting on Aplastic Anemia and PNH. This is an advanced presentation.
Danicopan
VOYDEYA is a prescription medicine used along with ravulizumab or eculizumab eculizumab: Eculizumab (Soliris ®) is given as an IV into a vein at the doctor’s office or at a special cen
Advances in Treating Aplastic Anemia
Topic(s)
Aplastic Anemia
Presenter(s)
Ronald Paquette, MD
In this webinar, Dr. Ronald Paquette discusses the latest advances in treating aplastic anemia. This was also recorded from a live session at the Los Angeles Patient and Family Conference in April, 2024, with questions from the live audiences online and in-person.
Biosimilars
What is a Biosimilar?
A biosimilar is a type of biologic medication. The term “biosimilar” means that the medication is highly similar to the already approved brand name biologic (“originator” medication). Biosimilars are not generic versions of the original biologic.
